These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5020420)

  • 1. Abscence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly.
    Carlson HE; Gillin JC; Gorden P; Snyder F
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1102-5. PubMed ID: 5020420
    [No Abstract]   [Full Text] [Related]  

  • 2. Nocturnal growth hormone secretion in acromegaly and obesity without electroencephalographic monitoring.
    Mims RB; Lopez RJ
    J Natl Med Assoc; 1976 May; 68(3):206-10. PubMed ID: 933190
    [No Abstract]   [Full Text] [Related]  

  • 3. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic value of hGH glucose suppression test in acromegaly (author's transl)].
    Deng JY
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):467-70. PubMed ID: 7338080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acromegaly].
    Lindholm J; Korsgaard O; Rasmussen P; Kappelgaard AM
    Ugeskr Laeger; 1973 Jan; 135(4):183-7. PubMed ID: 4346376
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects.
    Mims RB; Stein RB; Bethune JE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):34-9. PubMed ID: 4715294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.
    Nakagawa K; Mashimo K
    J Clin Endocrinol Metab; 1973 Aug; 37(2):238-46. PubMed ID: 4720071
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenergic modulation of growth hormone secretion in acromegaly: suppression during phentolamine and phentolamine-isoproterenol administration.
    Cryer PE; Daughaday WH
    J Clin Endocrinol Metab; 1974 Oct; 39(4):658-63. PubMed ID: 4411883
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dexamethasone on plasma growth hormone levels in acromegaly.
    Nakagawa K; Horiuchi Y; Mashimo K
    J Clin Endocrinol Metab; 1970 Nov; 31(5):502-6. PubMed ID: 4919042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma levels of growth hormone and insulin in acromegaly].
    Derot M; Rosselin G; Assan R; Freychet P; Tchobroutsky G
    Ann Endocrinol (Paris); 1966; 27(6):776-83. PubMed ID: 5973131
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary excretion of cortisol in acromegaly.
    Lindholm J; Kehlet H; Riishede J
    J Clin Endocrinol Metab; 1980 Apr; 50(4):796-8. PubMed ID: 6245103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 19. Acromegaly with 'normal' growth hormone levels.
    Feingold KR; Lorenz TJ
    West J Med; 1985 Jan; 142(1):95-7. PubMed ID: 3976225
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
    Nakagawa K; Akikawa K; Matsubara M; Kubo M
    J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.